Video-supported Training in Line With the Health Belief Model
NCT ID: NCT06138379
Last Updated: 2026-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2023-12-01
2024-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The research will be conducted as a randomized controlled experimental study. The population of the research will consist of adult patients who received liver transplantation at İnönü University Turgut Özal Medical Center. The sample will consist of 90 patients determined by power analysis. Patients will be divided into three groups: control (n=30), 1st experiment (n=30) and 2nd experiment (n=30). Data will be collected between August 2023 and December 2023 using the Patient Information Form, Chronic Disease Adaptation Scale, Immunosuppressive Drug Use Compliance Scale and Rational Drug Use Scale. Video-supported training will be provided to patients in the experimental group to increase compliance with the disease and immunosuppressive treatment and to ensure rational drug use. Patients in the 1st experimental group will receive video-supported training in line with the Health Belief Model for one month, and patients in the 2nd experimental group will receive video-supported standard training for one month. This video training will be given to the experimental group patients outside the routine nursing care of the clinic. The video-supported training is planned to last 20-30 minutes. Nursing care in the routine practice of the clinic will be applied to the control group. Evaluation of data; It will be done with number, percentage, mean, standard deviation, chi-square, paired t test, t test analysis in independent groups, ANOVA and ANCOVA.
As a result, it is predicted that video-supported education will increase compliance with chronic disease and medication use and reduce post-transplant symptoms and discomfort caused by these symptoms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Education on Quality of Life, Adherence to Immunosuppressive Therapy and Symptom Control in Organ Transplant Patients
NCT07288918
Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation
NCT06879106
Determining the Effect of Individualized Education Program in Kidney Transplant Patients
NCT06674239
The Knowledge Levels and Attitudes of the People Living in Nevşehir on Organ Donation and Transplantation
NCT02931318
Validity and Reliability of the Turkish Version of the Post-Liver Transplant Quality of Life Questionnaire
NCT06577480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
No Intervention: Control group The research will begin after obtaining the necessary legal and ethical permissions to collect data. At this stage of the research, participants who agree to participate in the research will be asked to fill out an informed consent form. All forms will be filled in to obtain pre-test data for the research.
These individuals who receive and continue to receive standard care will be informed about the research. Pre-test and post-test data from the control group will be obtained simultaneously with the study groups.
No interventions assigned to this group
1. Experimental Group
Experimental: Experimental group given video-supported training in line with the health belief model.
All forms (Patient Information Monitoring Form, Chronic Disease Adaptation Scale, Rational Drug Use Scale and Immunosuppressive Drug Form Scale) will be filled in to obtain pre-test data for the research. Individuals will be trained according to the training materials prepared for the Health Belief Model. They will be monitored one day each week. After 30 days, all forms will be filled out again to examine the sustainability of the training data.
Experimental: 1st Experimental Group
Individuals will be sent relevant educational videos after liver transplantation and asked to watch them.
2. Experimental Group
Experimental: The experimental group was given video-supported training in line with Classical Education.
All forms (Patient Information Monitoring Form, Chronic Disease Adaptation Scale, Rational Drug Use Scale and Immunosuppressive Drug Form Scale) will be filled in to obtain pre-test data for the research. Individuals will be trained according to the training materials prepared for the Health Belief Model. They will be monitored one day each week. After 30 days, all forms will be filled out again to examine the sustainability of the training data.
Experimental: 2nd Experimental Group
Individuals will be sent relevant educational videos after liver transplantation and asked to watch them.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental: 1st Experimental Group
Individuals will be sent relevant educational videos after liver transplantation and asked to watch them.
Experimental: 2nd Experimental Group
Individuals will be sent relevant educational videos after liver transplantation and asked to watch them.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 2 months and at most 2 years have passed since the transplant,
* Having a device (phone, tablet, computer, etc.) that can watch the video,
* Patients who are literate will be included in the study.
Exclusion Criteria
* Patients with distressing medical conditions will be excluded from the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inonu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zeliha CENGİZ
Associate Professor Dr. Zeliha CENGİZ, Head of the Department of Nursing Principles
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sezai Yılmaz, Prof Dr
Role: STUDY_DIRECTOR
Turgut Ozal Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turgut Ozal Medical Center
Malatya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/4674
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.